on 602 cases of Percutaneous Ozone Puncture Chemonucleolysis Treating Lumbar
He Qing, Du Feng, Li Tao, Luo Hui, Lei Xiao Fang, Lian Dong
Summary - We further studied the reliability, safety and utility of percutaneous ozone-puncture chemonucleolysis (POC) to treat lumbar disc protrusion, and compared this therapy with other mini-traumatic treatments. We adopt the methods of needle percutaneous puncture, and internal and external injection into the intervertebral disc: concentration 45-55 mg/L, O3 inner disc oxidation dosage 4-9 ml, exterior disc and intervertebral foramen 10ml, average hospital stay, five days. We treated 602 patients and 1078 intervertebral disc, including 238 mono-disc, 255 bi-disc, 106 tris-disc, and 3 tetra-disc. The oldest patient was 83 and the youngest 17 years, with 3-24 months’ follow-up and an 87.9% excellency rate. Within 12 hours after treatment, 40% patients had mild discomfort and the symptoms subsided automatically within 24 hours. Compared with other mini-traumatic invasive technologies, its prominent advantages are high safety, minimum distress, straightforward, easy to master technique, lost cost and obvious safer for patients. After previous trial usage in a small cohort of patients, within the last two years, the treatment has been applied to more patients with observation and clinical study. POC is the first choice for patients with lumbar disc protrusion, and local hospitals have more advantages of developing this technology.